| Daniel J Townsend, MD | |
|
175 Cambridge St, C/o Prooptical, Boston, MA 02114-2743 | |
| (617) 723-3937 | |
| (617) 523-5006 |
| Full Name | Daniel J Townsend |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 44 Years |
| Location | 175 Cambridge St, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003800749 | NPI | - | NPPES |
| 6175244 | Medicaid | MA | |
| J02653 | Other | MA | FORMER ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 48007 (Massachusetts) | Primary |
| Entity Name | Andover Eye Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588678551 PECOS PAC ID: 4486627866 Enrollment ID: O20040813001121 |
News Archive
According to a new study some doctors apparently consider it perfectly acceptable to withhold information regarding issues such as birth control, abortion and sedating dying patients, and even more of the medical profession feel under no obligation to tell patients where or how they access such advice or care.
New research published Online First in The Lancet suggests that drug-resistant HIV has been increasing in parts of Sub-Saharan Africa since the roll-out of antiretroviral therapy (ART) nearly a decade ago.
Aptus Endosystems Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced that several patients with aortic aneurysm disease have been successfully treated with the Aptus EndoStapling System in Europe. The innovative helical staple technology enables independent endograft fixation, and is designed to approximate suturing in an open surgical anastomosis. The company continues to build on its U.S. clinical experience which includes 176 patients and deployment of more than 900 EndoStaples.
Maximus, a business unit of leading infusion therapy firm Medegen Inc., has introduced its MaxPlus Clear positive displacement connector for use in patient care.
› Verified 9 days ago
| Entity Name | Post Oconnor & Kadrmas Eye Centers Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447325857 PECOS PAC ID: 5597713537 Enrollment ID: O20050106000702 |
News Archive
According to a new study some doctors apparently consider it perfectly acceptable to withhold information regarding issues such as birth control, abortion and sedating dying patients, and even more of the medical profession feel under no obligation to tell patients where or how they access such advice or care.
New research published Online First in The Lancet suggests that drug-resistant HIV has been increasing in parts of Sub-Saharan Africa since the roll-out of antiretroviral therapy (ART) nearly a decade ago.
Aptus Endosystems Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced that several patients with aortic aneurysm disease have been successfully treated with the Aptus EndoStapling System in Europe. The innovative helical staple technology enables independent endograft fixation, and is designed to approximate suturing in an open surgical anastomosis. The company continues to build on its U.S. clinical experience which includes 176 patients and deployment of more than 900 EndoStaples.
Maximus, a business unit of leading infusion therapy firm Medegen Inc., has introduced its MaxPlus Clear positive displacement connector for use in patient care.
› Verified 9 days ago
| Entity Name | North End Community Health Committee, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780606608 PECOS PAC ID: 8224043971 Enrollment ID: O20060216000209 |
News Archive
According to a new study some doctors apparently consider it perfectly acceptable to withhold information regarding issues such as birth control, abortion and sedating dying patients, and even more of the medical profession feel under no obligation to tell patients where or how they access such advice or care.
New research published Online First in The Lancet suggests that drug-resistant HIV has been increasing in parts of Sub-Saharan Africa since the roll-out of antiretroviral therapy (ART) nearly a decade ago.
Aptus Endosystems Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced that several patients with aortic aneurysm disease have been successfully treated with the Aptus EndoStapling System in Europe. The innovative helical staple technology enables independent endograft fixation, and is designed to approximate suturing in an open surgical anastomosis. The company continues to build on its U.S. clinical experience which includes 176 patients and deployment of more than 900 EndoStaples.
Maximus, a business unit of leading infusion therapy firm Medegen Inc., has introduced its MaxPlus Clear positive displacement connector for use in patient care.
› Verified 9 days ago
| Entity Name | Daniel J. Townsend, Md, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427089366 PECOS PAC ID: 7719983600 Enrollment ID: O20061017000424 |
News Archive
According to a new study some doctors apparently consider it perfectly acceptable to withhold information regarding issues such as birth control, abortion and sedating dying patients, and even more of the medical profession feel under no obligation to tell patients where or how they access such advice or care.
New research published Online First in The Lancet suggests that drug-resistant HIV has been increasing in parts of Sub-Saharan Africa since the roll-out of antiretroviral therapy (ART) nearly a decade ago.
Aptus Endosystems Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced that several patients with aortic aneurysm disease have been successfully treated with the Aptus EndoStapling System in Europe. The innovative helical staple technology enables independent endograft fixation, and is designed to approximate suturing in an open surgical anastomosis. The company continues to build on its U.S. clinical experience which includes 176 patients and deployment of more than 900 EndoStaples.
Maximus, a business unit of leading infusion therapy firm Medegen Inc., has introduced its MaxPlus Clear positive displacement connector for use in patient care.
› Verified 9 days ago
| Entity Name | Eye Health Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952653131 PECOS PAC ID: 0244482883 Enrollment ID: O20121206000285 |
News Archive
According to a new study some doctors apparently consider it perfectly acceptable to withhold information regarding issues such as birth control, abortion and sedating dying patients, and even more of the medical profession feel under no obligation to tell patients where or how they access such advice or care.
New research published Online First in The Lancet suggests that drug-resistant HIV has been increasing in parts of Sub-Saharan Africa since the roll-out of antiretroviral therapy (ART) nearly a decade ago.
Aptus Endosystems Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced that several patients with aortic aneurysm disease have been successfully treated with the Aptus EndoStapling System in Europe. The innovative helical staple technology enables independent endograft fixation, and is designed to approximate suturing in an open surgical anastomosis. The company continues to build on its U.S. clinical experience which includes 176 patients and deployment of more than 900 EndoStaples.
Maximus, a business unit of leading infusion therapy firm Medegen Inc., has introduced its MaxPlus Clear positive displacement connector for use in patient care.
› Verified 9 days ago
| Entity Name | Eye Health Associates Spn Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225444979 PECOS PAC ID: 3173744968 Enrollment ID: O20141020002141 |
News Archive
According to a new study some doctors apparently consider it perfectly acceptable to withhold information regarding issues such as birth control, abortion and sedating dying patients, and even more of the medical profession feel under no obligation to tell patients where or how they access such advice or care.
New research published Online First in The Lancet suggests that drug-resistant HIV has been increasing in parts of Sub-Saharan Africa since the roll-out of antiretroviral therapy (ART) nearly a decade ago.
Aptus Endosystems Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced that several patients with aortic aneurysm disease have been successfully treated with the Aptus EndoStapling System in Europe. The innovative helical staple technology enables independent endograft fixation, and is designed to approximate suturing in an open surgical anastomosis. The company continues to build on its U.S. clinical experience which includes 176 patients and deployment of more than 900 EndoStaples.
Maximus, a business unit of leading infusion therapy firm Medegen Inc., has introduced its MaxPlus Clear positive displacement connector for use in patient care.
› Verified 9 days ago
| Entity Name | Nantucket Ophthalmology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063164044 PECOS PAC ID: 5890175822 Enrollment ID: O20220707002283 |
News Archive
According to a new study some doctors apparently consider it perfectly acceptable to withhold information regarding issues such as birth control, abortion and sedating dying patients, and even more of the medical profession feel under no obligation to tell patients where or how they access such advice or care.
New research published Online First in The Lancet suggests that drug-resistant HIV has been increasing in parts of Sub-Saharan Africa since the roll-out of antiretroviral therapy (ART) nearly a decade ago.
Aptus Endosystems Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced that several patients with aortic aneurysm disease have been successfully treated with the Aptus EndoStapling System in Europe. The innovative helical staple technology enables independent endograft fixation, and is designed to approximate suturing in an open surgical anastomosis. The company continues to build on its U.S. clinical experience which includes 176 patients and deployment of more than 900 EndoStaples.
Maximus, a business unit of leading infusion therapy firm Medegen Inc., has introduced its MaxPlus Clear positive displacement connector for use in patient care.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel J Townsend, MD 175 Cambridge St, Boston, MA 02114-2743 Ph: (617) 723-3937 | Daniel J Townsend, MD 175 Cambridge St, C/o Prooptical, Boston, MA 02114-2743 Ph: (617) 723-3937 |
News Archive
According to a new study some doctors apparently consider it perfectly acceptable to withhold information regarding issues such as birth control, abortion and sedating dying patients, and even more of the medical profession feel under no obligation to tell patients where or how they access such advice or care.
New research published Online First in The Lancet suggests that drug-resistant HIV has been increasing in parts of Sub-Saharan Africa since the roll-out of antiretroviral therapy (ART) nearly a decade ago.
Aptus Endosystems Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced that several patients with aortic aneurysm disease have been successfully treated with the Aptus EndoStapling System in Europe. The innovative helical staple technology enables independent endograft fixation, and is designed to approximate suturing in an open surgical anastomosis. The company continues to build on its U.S. clinical experience which includes 176 patients and deployment of more than 900 EndoStaples.
Maximus, a business unit of leading infusion therapy firm Medegen Inc., has introduced its MaxPlus Clear positive displacement connector for use in patient care.
› Verified 9 days ago
Dr. Maan Sulaiman A Alkharashi, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Fegan 4, Boston, MA 02115 Phone: 857-523-6040 | |
Daniel Robert Lefebvre, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, 10th Floor -- Ophthalmic Plastic Surgery, Boston, MA 02114 Phone: 617-523-7900 | |
Dr. Seanna Rae Grob, MD, MAS Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-523-7900 | |
Ravi Parikh, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3288 | |
Michael V Boland, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-573-3611 | |
Dr. Parvathy A Pillai, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 243 Charles St, Boston, MA 02114 Phone: 617-647-1226 Fax: 617-573-3181 |